In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
Titel:
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
Auteur:
Syguła, Aleksandra Ledwon, Aleksandra Hasse-Lazar, Kornelia Jurecka-Lubieniecka, Beata Michalik, Barbara Paliczka-Cieślik, Ewa Zeman, Marcin Chmielik, Ewa Sczasny, Joanna Jarzab, Barbara Handkiewicz-Junak, Daria
Verschenen in:
European journal of nuclear medicine and molecular imaging